Venture Development Lead | Encure Biotherapeutics (Houston, USA)

Biopatrika; United States; On-site; USD 83,000 - 152,000; Part time

Benefits offered by this job

Founder-level equity

Job summary

Encure Biotherapeutics in Houston, TX seeks a Venture Development Lead to shape capital strategy, biopharma alliances and platform programs. This part-time role offers a clear path to full-time equity ownership as the company advances toward key investor milestones.

You will originate and structure seed financing, forge research collaborations, licensing deals and spin-out opportunities, and help turn early science into value with founder-level equity and strategic partnerships across biotech

Qualifications

• Experience shaping capital strategy and investor relations.
• Proven ability to originate biopharma partnerships and licensing deals.
• Track record in identifying and structuring spin-out programs.

Responsibilities

• Shape seed financing and build relationships across biotech and AI funds.
• Originate and structure research collaborations, co-development and licensing deals.
• Identify indication-specific programs and help structure spin-outs.

Skills

Capital strategy

Biopharma partnerships

New ventures

Job description

Hiring: Venture Development Lead | Encure Biotherapeutics (Houston, USA) Part-time to start → clear path to full-time, with founder-level equity

Help shape Encure's capital strategy, biopharma alliances and the programs that come out of our platform.

What makes Encure different

Most AI discovery platforms optimize the molecule first and solve delivery later. SWATI-AI designs the therapeutic, its soft-matter delivery vehicle and its safety profile together. It is built to address delivery, formulation stability and bioavailability at the design stage. We're building near the Texas Medical Center and looking for an entrepreneurial commercial partner to help turn this into strong investor syndicates and biopharma partnerships.

What you'll drive

• Capital strategy: shape our seed financing and build relationships across biotech, deep-tech and AI funds
• Biopharma partnerships: originate and structure research collaborations, co-development and licensing deals
• New ventures: identify focused, indication-specific programs and help structure spin-outs

Who should reach out

An experienced biotech venture builder, BD/licensing executive or fundraising lead who has moved early-stage biology toward value inflection.

• A track record of closing early-stage biotech rounds or BD/licensing deals
• Fluency in drug delivery (LNPs, soft matter), computational platforms or translational oncology
• Comfortable setting strategy and personally opening doors